Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 Mar 6;20(1):28.
doi: 10.1186/s12954-023-00760-7.

Contraception use among individuals with substance use disorder increases tenfold with patient-centered, mobile services: a quasi-experimental study

Emily A Hurley  1   2   3 , Kathy Goggin  4   5   6 , Kimberly Piña-Brugman  4 , Janelle R Noel-MacDonnell  4   5 , Andrea Allen  7 , Sarah Finocchario-Kessler  8 , Melissa K Miller  5   9
Affiliations
Clinical Trial

Contraception use among individuals with substance use disorder increases tenfold with patient-centered, mobile services: a quasi-experimental study

Emily A Hurley et al. Harm Reduct J. .

Abstract

Background: Individuals with substance use disorders (SUD) have disproportionately high rates of unintended pregnancy. Reducing harm associated with this risk and its biopsychosocial consequences requires evidence-based, non-coercive interventions that ensure access to contraception for individuals who choose to prevent pregnancy. We examined feasibility and impact of SexHealth Mobile, a mobile unit-based intervention that aimed to increase access to patient-centered contraceptive care for individuals in SUD recovery programs.

Methods: We conducted a quasi-experimental study (enhanced usual care [EUC] followed by intervention) at three recovery centers with participants (n = 98) at risk for unintended pregnancy. EUC participants were offered printed information on community locations where they could access contraception care. SexHealth Mobile participants were offered same-day, onsite clinical consultation on a medical mobile unit and contraception if desired. The primary outcome was use of contraception (hormonal or intrauterine device) at one-month post-enrollment. Secondary outcomes were at two-weeks and three-months. Confidence in preventing unintended pregnancy, reasons for non-use of contraception at follow-up, and intervention feasibility were also assessed.

Results: Participants (median age = 31, range 19-40) enrolled in the intervention period were almost 10 times more likely to be using contraception at one-month (51.5%) versus the those enrolled in the EUC period (5.4%) (unadjusted relative risk [URR] = 9.3 [95%CI: 2.3-37.1]; adjusted relative risk [ARR] = 9.8 [95%CI: 2.4-39.2]). Intervention participants were also more likely to be using contraception at 2-weeks (38.7% vs. 2.6%; URR = 14.3 [95%CI: 2.0-104.1]) and three-months (40.9% vs. 13.9%; URR = 2.9 [95% CI: 1.1-7.4]). EUC participants reported more barriers (cost, time) and less confidence in preventing unintended pregnancies. Mixed-methods feasibility data indicated high acceptability and feasible integration into recovery settings.

Conclusions: Mobile contraceptive care based on principles of reproductive justice and harm reduction reduces access barriers, is feasible to implement in SUD recovery settings, and increases contraception use. Expanding interventions like SexHealth Mobile may help reduce harm from unintended pregnancies among individuals in SUD recovery. Trial Registration NCT04227145.

Keywords: Contraception; Mobile unit; Recovery; Reproductive justice; Sexual health; Substance use disorders.

PubMed Disclaimer

Conflict of interest statement

EAH and MKM received investigator-initiated grants from Organon & Co for studies on contraception access. All other authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Screening, enrollment, & follow-up of participants in SexHealth Mobile Intervention
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Shafique S, Umer A, Innes KE, Rudisill TM, Fang W, Cottrell L. Preconception substance use and risk of unintended pregnancy: pregnancy risk assessment monitoring system 2016–17. J Addict Med. 2021 doi: 10.1097/ADM.0000000000000886. - DOI - PMC - PubMed
    1. Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioid-abusing women. J Subst Abus Treat. 2011;40(2):199–202. doi: 10.1097/CCM.0b013e31823e986a.A. - DOI - PMC - PubMed
    1. Haight SC, Ko JY, Van Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. Morb Mortal Wkly Rep. 2018;67(31):845–849. doi: 10.15585/mmwr.mm6731a1. - DOI - PMC - PubMed
    1. Admon LK, Bart G, Kozhimannil KB, Richardson CR, Dalton VK, Winkelman TNA. Amphetamine-And opioid-affected births: incidence, outcomes, and costs, United States 2004–2015. Am J Public Health. 2019 doi: 10.2105/AJPH.2018.304771. - DOI - PMC - PubMed
    1. Czeisler MÉ, Lane RI, Petrosky E, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic—United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020. 10.15585/mmwr.mm6932a1 - PMC - PubMed

Publication types

Substances

Associated data